Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
BioSymetrics, a phenomics-driven AI drug discovery company, announces that Yolanda Sanchez has joined its strategic advisory board earlier this year. ...
BioSymetrics, a phenomics-driven AI drug discovery company, today announced that John Baldoni will join its strategic advisory board. John is a...
BioSymetrics, a phenomics-driven drug discovery company with a mission to translate human disease biology and advance precision medicines, today...
BioSymetrics, an AI-powered drug discovery company, today announced the appointments of Stacie Calad-Thomson as Chief Strategy Officer and Head of...
BioSymetrics, a biomedical artificial intelligence company that provides clinical insights and helps researchers develop drugs with greater speed and ...
BioSymetrics, a biomedical artificial intelligence company that helps researchers develop drugs with greater speed and precision, announced it has...
BioSymetrics Inc., a biomedical artificial intelligence (AI) company, today announced the release and general availability of the newest workflow...
BioSymetrics, an artificial intelligence and machine learning SaaS company, announces Dr. Calum MacRae as Senior Advisor. Dr. MacRae is an innovative ...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.